Upcoming | Infectious Diseases Conferences 2021 | Euro infectious Diseases 2021 | Infectious Diseases Meetings | London

Theme: Advanced epidemiological methods during Covid-19

Euro Infectious Diseases 2021

Tentative Program

Renowned Speakers

Stef Stienstra
Royal Dutch Navy
Netherlands

Ines Garcia-Garcia
University of Puerto Rico
USA

Jason A Thompson
Emergency Products & Research Inc
USA

Leena Bhattacharya Mithal
Northwestern University
USA

Durgesh Sinha
Temple University
USA

Glenn S Tillotson
Cempra Pharmaceuticals
USA

Francis J Castellino
University of Notre Dame
USA

Sofia Khalil
McGill University
Canada

Anna Moniuszko Malinowska
Medical University of Bialystok
Poland

Phillip E. Klebba
Kansas State University
USA

Soza Tharwat Mohammed Baban
University of Nottingham
UK

Euro Infectious Diseases 2021

We cordially invite you all the participants from all over the world to attend 13^th Euro-Global Conference on Infectious Diseases is going to be held during October 11-12, 2021 London, UK. The Conference highlights the theme “Advanced epidemiological methods during Covid-19".

Infectious Diseases are disorders caused by organisms such as Bacterial Infections viruses, Tropical Disease, fungi, or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of Microbiology especially Clinical and Diagnostic Microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases. Tetanus (500,000), Measles (1 Million), HIV/AIDS (1 Million), Hepatitis B (1.1 Million), Malaria (2.1 Million), Diarrhoea(3.1Million), Tuberculosis (3.1 Million), Respiratory Infections (4.4 Million).

Who should attend?

Microbiologists
Bacteriologists
Virologists
Parasitologists
Mycologists
Pathologists
Pharmacists
Epidemiologists
Dermatologists
Neurologist
Ophthalmologist
Cardiologist
Health Care Professionals

Why to attend?

With members from around the world focused on learning about Control and Treatment of Infection during Covid-19 and its advances in therapeutic and diagnostic market, Dermatological Infections this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World’s eminent speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Targeted Audience

Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
Infectious Diseases Researchers, Scientists, Faculties, Students
Infectious Diseases Associations and Societies
Medical Colleges
Pharmaceutical Companies and Industries
Medical Devices Manufacturing Companies
Drug Manufacturing Companies and Industries
Laboratory Technicians and Diagnostic Companies
Business Entrepreneurs and Industrialists
Training Institutes
Software Developing Companies
Data Management Companies

Young Research’s Awards at Infectious Diseases 2021

Infectious Diseases 2021 is intended to honor prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Infectious Diseases.

Young Research’s Awards at Infectious Diseases 2021 for the Nomination:

Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the Infectious Diseases 2021

YRF Registration benefits:

Young Scientist Award recognition certificate and memento to the winners
Infectious Diseases 2021 provides best Platform for your research through oral presentations.
Learn about career improvement with all the latest technologies by networking.
Provide an opportunity for research interaction and established senior investigators across the globe in the field of Infectious Diseases.
It is a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

YRF Registration Deadline

Till July 30 – $399
Till August 30 – $499
Till September 28 – $599

Track 1: Infectious Disease

An infection occurs when a microorganism enters a person’s body and causes harm. An infection is the invasion of an organism's body tissues by disease-causing agents, their multiplication, and the reaction of host tissues to the infectious agents and the toxins they produce. An infectious disease, also known as a transmissible disease or communicable disease, is an illness resulting from an infection. The microorganism uses that person’s body to sustain itself, reproduce, and colonize. These infectious microscopic organisms are known as pathogens, and they can multiply quickly.

17^th World Congress on Infection Prevention and Control June 07-08, 2021, Berlin, Germany; World Congress on Infectious Diseases and Rare Diseases September 20-21, 2021, Rome, Italy; 11^th World Congress on Rare Diseases and Orphan Drugs September 06-07, 2021, Berlin, Germany; 13^th Euro-Global Conference on Infectious Diseases October 11-12, 2021, London, UK; 11^th International Conference on Emerging Infectious Diseases, November 23, 2020, Webinar; 12^th International Conference on Epidemiology and Public Health September 23-24, 2020 Berlin, Germany;

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Europe: European Society for Clinical Microbiology and Infectious Diseases, British Society for Antimicrobial Chemotherapy, Society for General Microbiology, British Association for Sexual Health and HIV, British HIV Association, The Hospital Infection Society, Infection Prevention Society, British Society for Medical Mycology, The Royal Society of Tropical Medicine and Hygiene, Royal Society for Public Health.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 2: Bacterial Diseases

Bacteria are single-celled microorganisms, also known as prokaryotes. Experts estimate that there are at least 1 nonillion bacteria on Earth. A nonillion is a 1 followed by 30 zeros. Much of the Earth’s biomass comprises bacteria. Bacteria take three main shapes:

Spherical: These are known as cocci.
Rod-shaped: These have the name bacilli.
Spiral: Coiled bacteria are known as spirilla. If the coil of a spirillum is particularly tight, scientists call it a spirochete.

Bacteria can live in almost any type of environment, from extreme heat to intense cold, and some can even survive in radioactive waste. There are trillions of strains of bacteria, and few cause diseases in humans. Some of them live inside the human body, such as in the gut or airways, without causing harm. Some “good” bacteria attack “bad” bacteria and prevent them from causing sickness. However, some bacterial diseases can be deadly.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 3: Viral Infections

Viral infections occur due to infection with a virus. Viruses contain a small piece of genetic code, and a coat of protein and lipid (fat) molecules protects them. Viruses invade a host and attach themselves to a cell. As they enter the cell, they release their genetic material. This material forces the cell to replicate the virus, and the virus multiplies. When the cell dies, it releases new viruses, which infect new cells. Not all viruses destroy their host cell, however. Some of them change the function of the cell. Some viruses, such as human papillomavirus (HPV) and Epstein-Barr virus (EBV), can lead to cancer by forcing cells to replicate in an uncontrolled way. A virus can also target certain age groups, such as infants or young children. Viruses may remain dormant for a period before multiplying again. The person with the virus can appear to have fully recovered, but they may get sick again when the virus reactivates.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 4: Fungal Infections

A fungus is often a multicellular parasite that can decompose and absorb organic matter using an enzyme. However, some types, such as yeasts, are single celled. Fungi almost always reproduce by spreading single celled spores. The structure of a fungus is usually long and cylindrical, with small filaments branching from the main body. There are approximately 5.1 million species of fungus. Many fungal infections develop in the upper layers of the skin, and some progress to the deeper layers. Inhaled yeast or mold spores can sometimes lead to fungal infections, such as pneumonia, or infections throughout the body. These are also known as systemic infections. The body usually has a population of good bacteria that help maintain the balance of microorganisms.

These line the intestines, mouth, vagina, and other parts of the body. Those with a higher risk of developing a fungal infection include people who: use antibiotics for a long time have a weakened immune system, due, for example, to living with HIV or diabetes or receiving chemotherapy treatment have undergone a transplant, as they take medications to prevent their body from rejecting the new organ.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 5: Prions

Prions are misfolded proteins with the ability to transmit their misfolded shape onto normal variants of the same protein. They characterize several fatal and transmissible neurodegenerative diseases in humans and many other animals. It is not known what causes the normal protein to misfold, but the abnormal three-dimensional structure is suspected of conferring infectious properties, collapsing nearby protein molecules into the same shape. The word prion derives from "proteinaceous infectious particle". The hypothesized role of a protein as an infectious agent stands in contrast to all other known infectious agents such as viruses, bacteria, fungi, and parasites, all of which contain nucleic acids (DNA, RNA, or both).

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 6: Parasite

A parasite is an organism that lives within or on a host. The host is another organism. The parasite uses the host’s resources to fuel its life cycle. It uses the host’s resources to maintain itself. Parasites vary widely. Around 70 percent are not visible to the human eye, such as the malarial parasite, but some worm parasites can reach over 30 meters in length. Parasites are not a disease, but they can spread diseases. Different parasites have different effects.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 7: Dermatological Infections

Your skin is the largest organ of your body. Its function is to protect your body from infection. Sometimes the skin itself becomes infected. Skin infections are caused by a wide variety of germs, and symptoms can vary from mild to serious. Mild infections may be treatable with over-the-counter medications and home remedies, whereas other infections may require medical attention.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 8: Ophthalmological Infections

Eye infections occur when some harmful organism invades an area of your eye. The source of the infection is often bacterial or viral, but it may be due to some other cause. Treatment depends on the cause of the infection. Despite the cause, the symptoms that occur when you have an eye infection are typically similar. If you suspect you have an eye infection, have your physician evaluate the problem. There can be numerous types of eye infections that can include conjunctivitis, keratitis, acanthamoeba keratitis, blepharitis, uveitis, cellulitis, ocular herpes, endophthalmitis, chlamydia trachomatis, a sty, dacryostenosis corneal ulcers, and orbital cellulitis. When it comes to dealing with potential eye infections, prevention is the best cure.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 9: Urinary Tract Infection

A urinary tract infection, or UTI, is an infection in any part of your urinary system, which includes your kidneys, bladder, ureters, and urethra. If you are a woman, your chance of getting a urinary tract infection is high. Some experts rank your lifetime risk of getting one as high as 1 in 2, with many women having repeat infections, sometimes for years. About 1 in 10 men will get a UTI in their lifetime.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 10: Neurological Infections

Viruses and microorganisms sometimes invade the body, infecting various organs and causing everything from mild disturbances to serious problems. Bacterial organisms are often to blame, but animal parasites and fungi can also cause infection. Neurological infections occur when these viruses and organisms invade the nervous system.

Symptoms of Infection: Pain, swelling, redness, impaired function and fever are all characteristics of an infection. There may also be heat at the site of the infected area. In the case of some viral infections, drowsiness, confusion, and convulsions may occur.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 11: Tropical Disease

Tropical diseases are diseases that are prevalent in or unique to tropical and subtropical regions. The diseases are less prevalent in temperate climates, due in part to the occurrence of a cold season, which controls the insect population by forcing hibernation. However, many were present in northern Europe and northern America in the 17^th and 18^th centuries before modern understanding of disease causation. The initial impetus for tropical medicine was to protect the health of colonial settlers, notably in India under the British Raj. Insects such as mosquitoes and flies are by far the most common disease carrier, or vector. These insects may carry a parasite, bacterium or virus that is infectious to humans and animals.

Most often disease is transmitted by an insect "bite", which causes transmission of the infectious agent through subcutaneous blood exchange. Vaccines are not available for most of the diseases listed here, and many do not have cures. Human exploration of tropical rainforests, deforestation, rising immigration and increased international air travel and other tourism to tropical regions has led to an increased incidence of such diseases to non-tropical countries.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 12: Infection Prevention and Control

Infection prevention and control (IPC) is a scientific approach and practical solution designed to prevent harm caused by infection to patients and health workers. It is grounded in infectious diseases, epidemiology, social science, and health system strengthening. IPC occupies a unique position in the field of patient safety and quality universal health coverage since it is relevant to health workers and patients at every single health-care encounter. No country, no health-care facility, even within the most advanced and sophisticated health-care systems, can claim to be free of the problem of health care-associated infections. The need for having IPC programmes nationally and at the facility level is clearly reinforced within the WHO 100 Core Health Indicators list.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 13: Antibiotics

Antibiotics are grouped into "families" of similar types. Bacteria also are put together in groups of similar types, such as streptococcus or E. coli. Certain types of bacteria are especially susceptible to particular classes of antibiotics. Treatment can be targeted more precisely if your doctor knows what type of bacteria you are infected with. Antibiotics are usually reserved for bacterial infections because these types of drugs have no effect on illnesses caused by viruses. But sometimes it is difficult to tell which type of germ is at work. For example, pneumonia can be caused by a bacterium, a virus, a fungus, or a parasite. The overuse of antibiotics has resulted in several types of bacteria developing resistance to one or more varieties of antibiotics. This makes these bacteria much more difficult to treat.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 14: Obstetrics and Gynaecology

Postoperative infections are commonly seen in the obstetrics and gynaecology. These infections sometimes may be polymicrobial which means caused by several species of microorganisms. Early recognition and treatment can prevent a threat to the foetus.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 15: Paediatric Infectious Diseases

Paediatric infectious diseases are those occur in the children from birth to teen years. Two-third of the deaths of children in past 10 years was caused by infectious diseases. New-borns are at higher risk as their immune system is immature and cannot fight infections.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 16: Pharmacology and Therapeutics

Pharmacology and Therapeutics is a source for advances in human therapeutics, transcends the drug discovery and development. It includes the study of pathophysiology of infectious diseases and mechanism of drug action, adverse drug effects, therapeutics and toxicology.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 17: Vaccines

Vaccine is a biological preparation that supports immune system to fight particular diseases. It played a crucial role in saving lives and greatly changing the burden of many infectious diseases. Awareness and effectiveness of Vaccination has made many diseases rare over years.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Biomedical Engineering Techniques for Health Care

Biomedical engineering is a new approach in health technology assessment. It combines the design and problems solving skill of engineering with medical biological sciences to advance health care treatment.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 18: Molecular Diagnosis of Infectious Diseases

Molecular Diagnostic Techniques developed a revolution in the diagnosing and monitoring pattern of infectious diseases. Advances in molecular diagnostic techniques over the past 10 years initiated new approach for microbial identification and characterization.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Track 19: Public Health

Public health is the discipline which deals with the science and art of preventing infections by improving the health of population.

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Market Analysis

Infections and Infectious diseases can be transmitted from animals to people or from one person to another. They can be mild and self-resolve or develop into serious illnesses if left untreated lead to serious illness, long-term consequences, or death.

Two contrasting trends are apparent in the infectious disease market. On one hand, the market has witnessed unprecedented growth in the antiviral and vaccine areas since 2010. In particular, the antiviral market has doubled in size—from $20 billion in 2010 to $42 billion in 2017—driven by therapeutic paradigm shifts, especially in the hepatitis C market. On the other hand, there has been a continued decline in the market for systemic antibacterial therapies, with annual revenues dropping from $15 billion in 2010 to $8 billion in 2017, owing to generic competition and limited pipeline innovation. This trend has ultimately contributed to fuelling the political momentum and debate on antimicrobial resistance and raising the awareness on the need to incentivize innovation in antibiotic drug discovery and development.

With a compounded annual growth rate (CAGR) of 3% from 2017– 2022, the infectious disease market is forecast to expand, but more slowly than the overall prescription drug market, for which a CAGR of 6% is expected in the same period. The HIV integrase inhibitor-based class—the leading growth driver—is expected to generate $7.2 billion in additional sales in 2022 compared with 2017, fuelled by Gilead’s (Biktarvy and Genvoya) and GlaxoSmithKline’s (Triumeq) combination therapies. The polyvalent immunoglobulin segment (Shire’s Gammagard and CSL’s Privigen) and pneumococcal vaccines (Pfizer’s Prevnar 13 and Merck & Co.’s Pneumovax) are expected to be the second and third largest therapeutic areas, with 2022 sales of $9.5 billion and $8 billion, respectively.

The global infectious diseases therapeutics market size was valued at USD 46.88 billion in 2016 and is projected to grow at a CAGR of 6.6% during the forecast period. Rising prevalence and increasing expenditure of infectious ailments to boost the penetration rate of treatments of the diseases, rising initiatives for creating awareness about treatments & diagnosis of these conditions, and increasing clinical trial studies for development of new drugs are to be the factors responsible for growth of this market.

The global IVD infectious diseases market size was valued at USD 18.8 billion in 2018. It is likely to exhibit a CAGR of 6.7% from 2018 to 2026. Increasing external funding for research and development (R&D) activities and proactive government initiatives are among the primary growth stimulants for the market.

Based on the types of diseases, the market is segmented into HIV, malaria, hepatitis, influenza, Human Papillomavirus (HPV), and tuberculosis. In 2017, the Ebola segment held the largest share i.e., 49.8% of the market.

US is estimated to grow the rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to the infectious diseases. Current market trend shows that North America has the global market for infectious diseases therapeutics due to increasing incidence of infectious diseases due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. The main reasons behind the highest market of infectious diseases in the above countries are mainly due to large number of patients and due to increase in government funding.

Infectious Diseases Diagnostics Market:

Infectious disease molecular diagnostics tests include hospitals, blood banks, and reference laboratories. North America has the highest global market for molecular diagnostics followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis, and bacterial infections. Countries like Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years.

A closer look at the early and late-stage pipeline broadly confirms the key commercial trends in the market. Figure 3 clearly shows how vaccines and antivirals take the lion’s share of all the development activities: 71% of all the phase 1 and 2 compounds and 60% of all phase 3 assets in pipeline are in one of those two classes. Emerging BioSolutions’ NuThrax (anthrax vaccine) tops the list of the best-selling research and development (R&D) products in 2022, with a sell-side consensus forecast of $870 million according to Evaluate. However, pockets of R&D activities are emerging in the broad systemic antibacterial area and, on a smaller scale, for antimalarial therapies (Box 1).

Fig. 3 | Infectious diseases pipeline. a, Top ten therapy areas in the early-stage (phase 1–2) pipeline (841 candidates). b, Top ten therapy areas in the late-stage (phase 3) pipeline (206 candidates). The pipeline includes potential new molecular entities, new derivatives, and potential candidates for new drug applications. Generics, biosimilars or over-the-counter products have not been accounted for. ImG, immunoglobulin G; Proto. Vx, protozoal vaccines; TB, tuberculosis.

Importance & Scope:

Infectious diseases are the second leading cause of world death rate, according to current estimates of the World Health Organization (WHO), the leading killers of children under five years of age. In spite of tremendous progress in Different Countries during the 20th century in reducing infectious disease deaths. When estimated, such deaths rank third behind cardiovascular disease and cancer in this country. With more than 1 billion people had crossed international borders in 2013. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014. The largest market share taken by antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market. In 2015, 6.5 million individuals were infected with Human Immunodeficiency Virus (HIV) and 28% of the HIV infected people are using antiretroviral therapy. Moreover, increasing availability of targeted drugs is expected to pose significant threat to the market during the forecast period. Global infectious disease therapeutics market size valued at $ 46.88 billion in 2016 and is projected to grow at a CAGR of 6.6% during the forecast period. The Infectious disease diagnostic (IDD) market is estimated to grow at a CAGR of 7.9% to reach $18,156.2 million by 2019.

We live with a crowded and interconnected planet, with a projected global human population of at least 9 billion by 2050. The urbanization of the human population is at the risk of transmission of many infectious agents. Currently, >80% of humans live in developing countries, rising prevalence of infectious ailments, increasing expenditure to boost the penetration rate of treatments of these diseases, rising initiatives and creating awareness about treatments & diagnosis of these conditions, and increasing clinical trial studies for development of new drugs are likely to be the factors responsible for growth of this market. However, lack of awareness and treatments for these disorders and low adoption of treatments are factors to restraint the growth in the coming years.

Target Audience:

Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
Infectious Diseases Researchers, Scientists, Faculties, Students
Infectious Diseases Associations and Societies
Medical Colleges
Pharmaceutical Companies and Industries
Medical Devices Manufacturing Companies
Drug Manufacturing Companies and Industries
Laboratory Technicians and Diagnostic Companies
Business Entrepreneurs and Industrialists
Training Institutes
Microbiologists, Bacteriologists, Virologists
Parasitologists, Mycologists, Pathologists
Pharmacists, Epidemiologists, Dermatologists
Neurologist, Ophthalmologist, Cardiologist
Health Care Professionals
Academic Professionals
Medical & Pharmacy Companies

Related Companies/Industries:

GlaxoSmithKline (GSK)
Gilead Sciences
Merck & Co.
Pfizer
Sanofi
CSL
AbbVie
Shire
Grifols
Johnson & Johnson
Roche
AstraZeneca
BMS
Eli Lilly
Cubist
Astellas Pharma
AMGEN

Related Associations and Societies:

European Society of Clinical Microbiology and Infectious Diseases
International Union of Microbiological Societies
Federation of Infection Societies
Canadian Society of Microbiologists
British Infection Association
Federation of European Microbiological Societies
Welsh Microbiology Association
Clinical Virology Network
American Society for Microbiology
Society for General Microbiology
Infectious Diseases Society of America
International Society for Infectious Diseases
Clinical Infectious Diseases Society
National Institute of Allergy and Infectious Disease
Pediatric Infectious Diseases Society
Institute for global health and infectious diseases
International Union Against Tuberculosis and Lung Disease, Paris, France
Australasian Society for Infectious Diseases
European Society for Paediatric Infectious Diseases
Society of Infectious Diseases Pharmacists

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	October 11-12, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View

Media Partners

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

Testimonials

It was wonderful event. I enjoyed presenting my talk. There were questions, comments, and interests in what I presented

Ram Shanmugam, Texas State University, USA

Very glad that I was able to speak at such a wonderful conference and appreciate the opportunity.

Mel Torrie, CEO, Autonomous Solutions, USA

The conference was exciting. I enjoyed so much meeting new colleagues at the venue. I would like to express my sincere gratitude to you for your assistance and opportunity. It was a good experience attending this conference.

Amur Margaryan, National Science Laboratory, USA

Congress was good with loads of information

Priyadharshini Arunachalam, UniversitÃ¤tsklinikum Hamburg-Eppendorf, Germany

The conference was well organized and the committee was outstanding in keeping the whole event lively

Mourad Tayebi, Professor University of Surrey, England

Thank you very much for your excellent organisation of Infectious Diseases. It was a great success.

Luke Hunt, Liverpool School of Tropical Medicine, UK

13^th Euro-Global Conference on Infectious Diseases October 11-12, 2021 London, UK

Recommended Global Infectious Diseases Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Euro Infectious Diseases 2021

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Useful Links

Special Issues

Testimonials